Search Results - "STIAKAKI, E"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias by PALOMERO, T, MCKENNA, K, ASTER, J. C, LOOK, A. T, FERRANDO, A. A, O-NEIL, J, GALINSKY, I, STONE, R, SUZUKAWA, K, STIAKAKI, E, KALMANTI, M, FOX, E. A, CALIGIURI, M. A

    Published in Leukemia (01-11-2006)
    “…Activating mutations in NOTCH1 are found in over 50% of human T-cell lymphoblastic leukemias (T-ALLs). Here, we report the analysis for activating NOTCH1…”
    Get full text
    Journal Article
  7. 7

    The Effect of RFC G80A Polymorphism in Cretan children with acute lymphoblastic leukemia and its interaction with MTHFR C677T and A1298C polymorphisms by Karathanasis, N. V., Stiakaki, E., Goulielmos, G. Ν., Kalmanti, M.

    “…Summary Introduction The association between the risk of acute lymphoblastic leukemia (ALL) in children and enzymes involved in the folate metabolism has been…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Could cord blood be a source of mesenchymal stromal cells for clinical use? by Perdikogianni, C, Dimitriou, H, Stiakaki, E, Martimianaki, G, Kalmanti, M

    Published in Cytotherapy (Oxford, England) (2008)
    “…Background Cord blood (CB) has long been regarded as an easily accessible source of hematopoietic progenitors suitable for transplantation, but its efficiency…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases by Dimitriou, H., PhD, Linardakis, E, Martimianaki, G, Stiakaki, E, Perdikogianni, C.H, Charbord, P, Kalmanti, M

    Published in Cytotherapy (Oxford, England) (2008)
    “…Background Mesenchymal stromal cells (MSC) have become the focus of cellular therapeutics but little is known regarding bone marrow (BM) MSC derived from…”
    Get full text
    Journal Article
  13. 13

    Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia by Spanaki, A, Linardakis, E, Perdikogianni, C, Stiakaki, E, Morotti, A, Cilloni, D, Kalmanti, M

    Published in Leukemia research (01-04-2007)
    “…Abstract The purpose of this study was to investigate WT1 expression levels in childhood acute leukemia. Bone marrow from 14 children with acute leukemia at…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia by Markaki, E.-A., Stiakaki, E., Zafiropoulos, A., Arvanitis, D.A., Katzilakis, N., Dimitriou, H., Spandidos, D.A., Kalmanti, M.

    Published in Pediatric Blood & Cancer (01-07-2006)
    “…Background Cyclin‐dependent kinases (CDKs) and cyclins, their regulatory subunits, govern cell‐cycle progression in eukaryotic cells. Kip1/p27 is the main…”
    Get full text
    Journal Article
  16. 16

    Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy by Dimitriou, H, Stiakaki, E, Markaki, E-A, Bolonaki, I, Giannakopoulou, Ch, Kalmanti, M

    Published in Acta Paediatrica (01-10-2000)
    “…Soluble transferrin receptor (sTfR) is a new diagnostic tool for determining iron status and erythropoietic activity. The increased concentrations of sTfR in…”
    Get full text
    Journal Article
  17. 17

    κ-opioids induce a reversible inhibition of CFU-GM from CD133+ cord blood cells by Dimitriou, H., Bakogeorgou, E., Kampa, M., Notas, G., Stiakaki, E., Kouroumalis, E., Kalmanti, M., Castanas, E.

    Published in Cytotherapy (Oxford, England) (2006)
    “…Opioid agonists have been shown to exert an inhibitory action on a number of malignant and non-malignant cell types. However, there are no reports dealing with…”
    Get full text
    Journal Article
  18. 18
  19. 19

    PB1647 EXPRESSION OF PHOSPHORYLATED AKT AND CLASS I PI3K ISOFORMS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA by Lourou, M., Papakonstanti, E., Yachnakis, E., Stiakaki, E.

    Published in HemaSphere (01-06-2019)
    “…Background : Acute lymphoblastic leukemia (ALL) is the most common neoplastic disease in children and represents 30% of all childhood malignancies. Although…”
    Get full text
    Journal Article
  20. 20